1. Home
  2. CFG vs UTHR Comparison

CFG vs UTHR Comparison

Compare CFG & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Group Inc.

CFG

Citizens Financial Group Inc.

HOLD

Current Price

$55.74

Market Cap

23.5B

Sector

Finance

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$483.96

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFG
UTHR
Founded
1828
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.5B
20.3B
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
CFG
UTHR
Price
$55.74
$483.96
Analyst Decision
Strong Buy
Buy
Analyst Count
18
12
Target Price
$55.83
$495.08
AVG Volume (30 Days)
3.9M
412.1K
Earning Date
01-16-2026
10-29-2025
Dividend Yield
3.01%
N/A
EPS Growth
41.06
16.08
EPS
3.57
26.38
Revenue
$7,443,000,000.00
$3,128,400,000.00
Revenue This Year
$17.05
$13.68
Revenue Next Year
$8.73
$5.63
P/E Ratio
$15.65
$18.40
Revenue Growth
4.61
13.50
52 Week Low
$32.60
$266.98
52 Week High
$56.05
$492.62

Technical Indicators

Market Signals
Indicator
CFG
UTHR
Relative Strength Index (RSI) 67.74 65.15
Support Level $53.78 $470.13
Resistance Level $54.64 $486.46
Average True Range (ATR) 1.21 10.39
MACD 0.39 -0.88
Stochastic Oscillator 93.72 70.12

Price Performance

Historical Comparison
CFG
UTHR

About CFG Citizens Financial Group Inc.

Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through the bank, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The company's reportable segments are; Commercial Banking, Consumer Banking, Non-Core, and Others. A majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management and investment services.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: